Xlife Sciences AG (SWX:XLS)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
24.00
+0.80 (3.45%)
At close: Jun 2, 2026
Market Cap136.85M +19.2%
Revenue (ttm)275.31K -67.0%
Net Income-21.55M
EPS-3.76
Shares Out 5.70M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,270
Open22.50
Previous Close23.20
Day's Range22.10 - 24.00
52-Week Range15.75 - 26.80
Beta0.42
Analystsn/a
Price Targetn/a
Earnings DateSep 24, 2026

About Xlife Sciences AG

Xlife Sciences AG focuses on the development and commercialization of research projects in the life sciences sector. The company’s project covers technology platforms, biotechnology/therapies, medical technology, and artificial intelligence/digital health areas that focuses on identifying new therapeutic approaches and biomarkers for common diseases based on human genetic data. It also produces, researches, develops, and manufactures the chemical and active pharmaceutical ingredients for human and veterinary medicines; and offers clinical resea... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2019
Employees 17
Stock Exchange SIX Swiss Exchange
Ticker Symbol XLS
Full Company Profile

Financial Performance

Financial Statements